| dc.description.sponsorship | This study was supported by Biogen International (Zug, Switzerland).r Tim Spelman: Received compensation for serving on scientific advisory boards, honoraria for consultancy and funding for travel from Biogen Inc and speaker honoraria from Novartisr Eva Havrdova: Received speaker honoraria and consultant fees from Biogen, Merck Serono, Novartis, Genzyme and Teva, as well as support for research activities from Biogen, Merck Serono and research grants from Charles University in Prague (PRVOUK-P26/LF1/4 and Czech Ministry of Health (NT13237-4/2012)r Dana Horakova: Received speaker honoraria and consulting fees from Biogen, Merck Serono, Teva and Novartis, as well as support for research activities from Biogen and research grants from Charles University, Prague (PRVOUK-P26/LF1/4) and Czech Ministry of Health (NT13237-4/2012)r Maria Trojano: Received speaker honoraria from Biogen-Idec, Bayer-Schering, Sanofi Aventis, Merck-Serono, Teva, Novartis and Almirall; has received research grants for her institution from Biogen-Idec, Merck Serono and Novartisr Alessandra Lugaresi: Bayer, Biogen, Genzyme, Merck Advisory Board Member. She received travel grants and honoraria from Bayer, Biogen, Merck, Novartis, Sanofi and Teva, research grants from the Associazione Italiana Sclerosi Multiplar Pierre Grammond: Is a Novartis, Teva-neuroscience, Biogen and Genzyme advisory board member, consultant for Merck Serono, received payments for lectures by Merck Serono, Teva-neuroscience and Canadian Multiple Sclerosis Society, and received grants for travel from Teva-neuroscience and Novartisr Eugenio Pucci: Served on scientific advisory boards for Genzyme and Biogen; he has received honoraria and travel grants from Sanofi Aventis, UCB, Lundbeck, Novartis, Bayer Schering, Biogen, Merck Serono, Genzyme and Teva; he has received travel grants from Associazone Marchigana Sclerosi Multipla e altre malattie neurologicher Franco Granella: Has served on scientific advisory boards for Biogen Idec, Novartis and Sanofi Aventis and received funding for travel and speaker honoraria from Biogen Idec, Merck Serono, and Almirallr Jeannette Lechner-Scott: Has accepted travel compensation from Novartis, Biogen and Merck Serono.; Her institution receives the honoraria for talks and advisory board commitment and also clinic support from Bayer Health Care, Biogen, CSL, Genzyme Sanofi, Merck Serono and Novartisr Patrizia Sola: Received travel grants and speaking honoraria from Bayer Schering, Biogen, Merck Serono, Novartis, Sanofi/Genzyme and Tevar Diana Ferraro: Received travel grants and/or speaker honoraria from Merck Serono, Biogen, TEVA, Novartis, Sanofi-Genzymer Francois Grand'Maison: Received honoraria or research funding from Biogen, Genzyme, Novartis, Teva Neurosciences, Mitsubishi and ONO Pharmaceuticalsr Murat Terzi: Received travel grants from Merck Serono, Novartis, Bayer Schering and Teva and has participated in clinical trials by Sanofi-Aventis, Roche and Novartisr Csilla Rozsa: Received speaker honoraria from Bayer Schering, Novartis and Biogen, congress and travel expense compensations from Biogen, Teva, Merck Serono and Bayer Scheringr Raymond Hupperts: Received honoraria as consultant on scientific advisory boards from Merck-Serono, Biogen, Genzyme-Sanofi and Teva, research funding from Merck-Serono and Biogen, and speaker honoraria from Sanofi-Genzyme and Novartisr Vincent Van Pesch: Served on advisory boards for Biogen, Novartis Pharma and Sanofi-Genzyme; has received travel grants and consultancy fees from Biogen, Bayer Schering, Sanofi Aventis, Merck Serono, Sanofi-Genzyme and Novartis Pharma; has received research grants from Bayer Scheringr Tomas Kalincik: Served on an advisory scientific board from Merck-Serono, has received conference travel support and speaker honoraria from Novartis, Biogen, Sanofi-Aventis, Genzyme, Teva, BioCSL and Merck Serono and has received research support from Biogenr Helmut Butzkueven: Served on scientific advisory boards for Biogen, Novartis and Sanofi-Aventis and has received conference travel support from Novartis, Biogen and Sanofi Aventis. He serves on steering committes for trials conducted by Biogen and Novartis, and has received research support from Merck Serono, Novartis and Biogen | en_US |
